Cleared Traditional

K983627 - VENTURE IHO 100 HOME FILL COMPLETE HOME OXYGEN SYSTEM

K983627 is an FDA 510(k) clearance for VENTURE IHO 100 HOME FILL COMPLETE HOME..., manufactured by Invacare Corp.. The device is a Class 2 Anesthesiology device with product code CAW cleared through the Traditional 510(k) pathway after a 372-day FDA review.

K983627 · Invacare Corp. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1999
Decision
372d
Days
Class 2
Risk

K983627 is an FDA 510(k) clearance for the VENTURE IHO 100 HOME FILL COMPLETE HOME OXYGEN SYSTEM. Classified as Generator, Oxygen, Portable within the CAW classification (a category for home-use oxygen therapy and respiratory devices), Class II - Special Controls.

Submitted by Invacare Corp. (Elyria, US). The FDA issued a Cleared decision on October 22, 1999 after a review of 372 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5440 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Invacare Corp. devices

FDA 510(k) Submission Details - K983627

510(k) Number K983627 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 15, 1998
Decision Date October 22, 1999
Days to Decision 372 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
232d slower than avg
Panel avg: 140d · This submission: 372d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CAW Device Classification - Class 2, Special Controls

Product Code CAW Generator, Oxygen, Portable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CAW Generator, Oxygen, Portable

All 209
Devices cleared under the same product code (CAW) and FDA review panel - the closest regulatory comparables to K983627.
INTEGRA OXYGEN CONCENTRATORS MODEL 6400-OM
K003472 · Sequal Technologies, Inc. · Jun 2001
VENTURE HOME FILL II, MODEL IOH 200
K003939 · Invacare Corp. · Mar 2001
DEVILBISS 5 LITER OXYGEN CONCENTRATOR
K991722 · Sunrise Medical Hhg, Inc. · Nov 1999
PURITAN-BENNETT AERIS 590 OXYGEN CONCENTRATOR WITH OCI
K993088 · Puritan Bennett Corp. · Oct 1999
FRESH AIR
K981047 · Colorado Medtech, Inc. · Sep 1999
HOME/COMMERCIAL OXYGEN UNIT BY SYSTEM O2
K991569 · 02 Marketing Group, Inc. · Aug 1999